Glimibose PM 2mg/500mg/15mg Tablet SR
Marketer
B.J.Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimibose PM 2mg/500mg/15mg Tablet SR
This extended-release tablet, Glimibose PM (2mg/500mg/15mg), combines medications to manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, it enhances insulin effectiveness, reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions; always take it with food to prevent digestive discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. An overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or missed meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before initiating treatment. Kidney function tests are typically performed before commencing therapy. Limit alcohol consumption to minimize potential adverse reactions.
Primary Ingredients of Glimibose PM 2mg/500mg/15mg Tablet SR
The information is unavailable.
Uses of Glimibose PM 2mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glimibose PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimibose PM 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Glimibose PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimibose PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimibose PM 2mg/500mg/15mg SR tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
How Glimibose PM 2mg/500mg/15mg Tablet SR works:
Glimibose PM 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when single or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Glimibose PM 2mg/500mg/15mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Glimibose PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimibose PM tablets (2mg/500mg/15mg) are likely unsuitable for breastfeeding mothers. Available evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired if your blood glucose levels are abnormally low or elevated. Refrain from driving should these conditions arise.
KidneyCAUTION
Patients with kidney impairment should use Glimibose PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimibose PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimibose PM 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glimibose PM 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Glimibose PM 2mg/500mg/15mg SR Tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimibose PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Medication for diabetes |
3,018 People bought this recently